β-内酰胺过敏去标签可缩短术中时间并优化抗生素预防选择
本研究采用过敏专科风险评估、β-内酰胺皮试和口服激发三步法对194例术前患者进行去标签评估。皮试阴性者中仅5%激发后过敏,77%需预防者最终选用头孢唑林,避免万古霉素平均节省22分钟手术时间。未行激发者仅50%使用β-内酰胺。
要点
- 三步法去标签使绝大多数自称青霉素过敏者安全使用β-内酰胺类。
- 去标签后头孢唑林成为77%需预防患者的选择,减少万古霉素使用。
- 避免万古霉素平均节省22分钟手术时间,提高手术效率。
核心结论
- 三步去标签流程使几乎所有自称青霉素过敏者去标签,β-内酰胺成为多数患者围术期首选。
- 减少万古霉素使用可缩短切皮前延迟,改善手术效率。
研究设计与样本
- 多步骤前瞻性评估:过敏专科风险评估工具、β-内酰胺皮试和口服激发。
- 共评估194例术前患者,皮试阴性190例中146例接受β-内酰胺激发。
主要发现
- 皮试诊断β-内酰胺过敏4例;190例皮试阴性者中146例激发,仅5%反应判为过敏。
- 77%需抗生素预防患者围术期选用头孢唑林;仅5例确诊过敏者术中使用万古霉素。
- 避免万古霉素平均节省22分钟手术时间;未行激发44例中36例用抗生素,18例(50%)用头孢唑林。
临床怎么用
- 对自称青霉素过敏的术前患者,可采用过敏专科风险评估、皮试和口服激发三步法去标签。
- 去标签后优先选用头孢唑林等β-内酰胺进行围术期预防,减少万古霉素使用以缩短切皮延迟。
局限性
- 需随机对照研究客观确定该方法的有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Suspected penicillin allergic individuals receive suboptimal non-β-lactams for intraoperative prophylaxis which may prolong operations and have negative clinical outcomes. We therefore studied if β-lactam de-labeling optimized choice of prophylactic antibiotics and improved intraoperative time efficiency. METHODS: A multistep approach was used. It included a risk assessment tool by an allergist, β-lactam skin testing and oral provocation. To determine the value of de-labeling, we appraised intraoperative antibiotic choices and correlated them with time to first incision. RESULTS: A total of 194 patients were evaluated preoperatively. Four patients were diagnosed β-lactam allergic on skin testing. Of the remaining 190 skin test negative patients, 146 were β-lactam challenged. Only 5% reacted and were considered β-lactam allergic. Cefazolin became the perioperative antibiotic of choice for 77% of patients requiring antibiotic prophylaxis. Only 5 confirmed β-lactam allergic patients received intraoperative vancomycin. Patients avoiding use of vancomycin saved an average of 22 minutes in operative time. Of the 44 patients not having a β-lactam challenge, 36 received antibiotics and 18 (50%) of these were prescribed intraoperative cefazolin. CONCLUSION: Using this three step process, almost all of those claiming penicillin allergy were de-labeled. In most patients that were drug challenged, β-lactam antibiotics became the perioperative drug of choice. In cases where oral challenge was not used in the assessment only 50% were given a β-lactam. The reduced use of vancomycin minimized delays in initiation of incision time, thus improving operative efficiency. Ultimately, randomized controlled studies are required to objectively determine the effectiveness of this approach.
引用
- Moussa Y, Shuster J, Matte G, et al. De-labeling of β-lactam allergy reduces intraoperative time and optimizes choice in antibiotic prophylaxis. Surgery. 2018. PMID: 29751965. doi:10.1016/j.surg.2018.03.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。